白三烯介导的神经炎症、中毒性脑损伤与急性甲醇中毒后的神经退行性变
该研究在28/101例住院急性甲醇中毒患者中连续检测半胱氨酰白三烯(LTC4、LTD4、LTE4)与LTB4的急性浓度及动态变化,并在36例幸存者出院2年后复测作为对照。急性期最大浓度均高于幸存者对照(如LTC4 80.7±5.6 vs 47.9±4.5 pg/mL,均p<0.001)。存活者急性期LT浓度高于死亡者(均p<0.01);幸存者中有中枢神经系统后遗症者LTE4和LTB4低于无后遗症者(均p<0.05)。LT浓度以0.4–0.5 pg/mL/h速率上升,入院后4–5天达峰;随访时有无CNS后遗症者LT浓度无差异(均p>0.05)。作者认为白三烯介导的神经炎症可能参与人急性甲醇中毒的毒性脑损伤机制。
要点
- 急性甲醇中毒患者急性期LTC4峰值80.7±5.6 pg/mL、LTD4 51.0±6.6 pg/mL、LTE4 64.2±6.0 pg/mL、LTB4 59.8±6.2 pg/mL,均高于幸存者2年后对照(均p<0.001)。
- 急性期LT浓度以0.4–0.5 pg/mL/h速率上升,入院后4–5天达峰,为中等程度、一过性升高。
- 存活者急性期LT浓度高于死亡者(均p<0.01);幸存者中有CNS后遗症者LTE4和LTB4低于无后遗症者(均p<0.05)。
- 中毒更严重(酸中毒更重)的患者急性LT浓度低于轻度酸血症者。
- 幸存者出院2年后有无CNS后遗症者LT浓度无差异(均p>0.05),未见慢性神经炎症。
适用人群与场景
- 住院急性甲醇中毒患者,共101例中28例纳入急性LT连续检测(平均观察时间88±20小时)。
- 36例幸存者于出院2年后进行对照LT检测。
研究设计与关键结果
- 研究类型:急性甲醇中毒患者血清白三烯浓度的系列检测研究;急性期检测28/101例住院患者(平均观察时间88±20小时),36例幸存者出院2年后复测作为对照。
- 急性最大浓度(Cmax):LTC4 80.7±5.6 vs 47.9±4.5 pg/mL;LTD4 51.0±6.6 vs 23.1±2.1 pg/mL;LTE4 64.2±6.0 vs 26.2±3.9 pg/mL;LTB4 59.8±6.2 vs 27.2±1.4 pg/mL(急性期 vs 幸存者对照,均p<0.001)。
- 存活者急性LT浓度高于死亡者(均p<0.01)。
- 幸存者中有CNS后遗症者LTE4和LTB4低于无后遗症者(均p<0.05)。
- LT浓度以0.4–0.5 pg/mL/h速率上升,入院后4–5天达峰。
- 结局较好者cys-LTs较高(均p<0.01)、LTB4较高(p<0.05);中毒更严重(酸中毒更重)者急性LT浓度低于轻度酸血症者。
- 随访时幸存者有无CNS后遗症者LT浓度无差异(均p>0.05)。
- LT浓度平均下降值:LTC4 30.9±9.0 pg/mL、LTD4 26.3±8.6 pg/mL、LTE4 37.3±6.4 pg/mL、LTB4 32.0±8.8 pg/mL。
证据类型、等级与局限
- 证据类型:临床观察性研究(系列检测),原文未报告证据等级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为白三烯介导的神经炎症可能在人类急性甲醇中毒的毒性脑损伤机制中起重要作用。
- 急性LT浓度升高为中等程度、一过性,幸存者未见慢性神经炎症。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
CONTEXT: The role of neuroinflammation in methanol-induced toxic brain damage has not been studied.
OBJECTIVE: We studied acute concentrations and the dynamics of leukotrienes (LT) in serum in hospitalized patients with acute methanol poisoning and in survivors.
METHODS: Series of acute cysteinyl-LT and LTB4 concentration measurements were performed in 28/101 hospitalized patients (mean observation time: 88 ± 20 h). In 36 survivors, control LT measurements were performed 2 years after discharge.
RESULTS: The acute maximum (Cmax) LT concentrations were higher than concentrations in survivors: Cmax for LTC4 was 80.7 ± 5.6 versus 47.9 ± 4.5 pg/mL; for LTD4, 51.0 ± 6.6 versus 23.1 ± 2.1 pg/mL; for LTE4, 64.2 ± 6.0 versus 26.2 ± 3.9 pg/mL; for LTB4, 59.8 ± 6.2 versus 27.2 ± 1.4 pg/mL (all p < 0.001). The patients who survived had higher LT concentrations than those who died (all p < 0.01). Among survivors, patients with CNS sequelae had lower LTE4 and LTB4 than did those without sequelae (both p < 0.05). The LT concentrations increased at a rate of 0.4-0.5 pg/mL/h and peaked 4-5 days after admission. The patients with better outcomes had higher cys-LTs (all p < 0.01) and LTB4 (p < 0.05). More severely poisoned patients had lower acute LT concentrations than those with minor acidemia. The follow-up LT concentrations in survivors with and without CNS sequelae did not differ (all p > 0.05). The mean decrease in LT concentration was 30.9 ± 9.0 pg/mL for LTC4, 26.3 ± 8.6 pg/mL for LTD4, 37.3 ± 6.4 pg/mL for LTE4, and 32.0 ± 8.8 pg/mL for LTB4.
CONCLUSIONS: Our findings suggest that leukotriene-mediated neuroinflammation may play an important role in the mechanisms of toxic brain damage in acute methanol poisoning in humans. Acute elevation of LT concentrations was moderate, transitory, and was not followed by chronic neuroinflammation in survivors.
参考来源
- Zakharov S, Kotikova K, Nurieva O, et al. Leukotriene-mediated neuroinflammation, toxic brain damage, and neurodegeneration in acute methanol poisoning. Clin Toxicol (Phila). 2017. PMID: 28165820. doi:10.1080/15563650.2017.1284332
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。